peer-reviewed Publications 2023
 
  1. Hepatitis delta infection among persons living with HIV in Europe. Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G; EuroSIDA and SHCS.
    Liver Int. 2023;43(4):819-828. Abstract
     
  2. Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients. Nørgaard JC, Jørgensen M, Moestrup KS, Ilett EE, Zucco AG, Marandi RZ, Julian MN, Paredes R, Lundgren JD, Sengeløv H, MacPherson C.
    J Infect Dis. 2023:jiad033. Epub ahead of print. Abstract
     
  3. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Surial B, Mena AR, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
    J Hepatol. 2023:S0168-8278(23)00011-9. Epub ahead of print.Abstract
     
  4. Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load. Gabrielaite M, Bennedbæk M, Rasmussen MS, Kan V, Furrer H, Flisiak R, Losso M, Lundgren JD; INSIGHT START Study Group; Marvig RL.
    PLoS Comput Biol. 2023;19(1):e1010756. Abstract
     
  5. Development of a machine learning model for early prediction of plasma leakage in suspected dengue patients. Zargari Marandi R, Leung P, Sigera C, Murray DD, Weeratunga P, Fernando D, Rodrigo C, Rajapakse S, MacPherson CR.
    PLoS Negl Trop Dis. 2023;17(3):e0010758. Abstract
     
  6. Superinfections in COVID-19 patients receiving extracorporeal membrane oxygenation support. V Andersen H, Jørgensen VRL, Steensen M, Pedersen FM, Helleberg M.
    Acta Anaesthesiol Scand. 2023. Epub ahead of print. Abstract
     
  7. Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study. Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem VN, Günthard HF, Zangerle R, Smith C, Castagna A, D Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group.
    Clin Infect Dis. 2023:ciad219. Epub ahead of print. Abstract
     
  8. Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Lundgren JD, Babiker AG, Sharma S, Grund B, Phillips AN, Matthews G, Kan VL, Aagaard B, Abo I, Alston B, Arenas-Pinto A, Avihingsanona, Badal-Faesen S, Brites C, Carey C, Casseb J, Clarke A, Collins S, Corbelli GM, Dao S, Denning ET, Emery S, Eriobu N, Florence E, Furrer H, Fätkenheuer G, Gerstoft J, Gisslen M, Goodall K, Henry K, Horban A, Hoy J, Hudson F, Azwa RISR, Kedem E, Kelleher A, Kityo C, Klingman K, La Rosa A, Leturque N, Lifson AR, Losso M, Lutaakome J, Sierra Madero J, Mallon P, Mansinho K, Marhoum El Filali K, Molina JM, Murray DD, Nagalingeswaran K, Nozza S, Ormaasen V, Paredes R, Peireira LC, Pillay S, Polizzotto MN, Raben D, Rieger A, Sanchez A, Schechter M, Sedlacek D, Staub T, TouloumiG, Turner M, Valdez Madruga J, Vjecha M, Wolff M, Wood R, Zilmer K, Lane C, Neaton JD
    NEJM Evid 2023; 2 (3). Abstract
     
  9. Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality. Terrones-Campos C, Ledergerber B, Forbes N, Smith AG, Petersen J, Helleberg M, Lundgren J, Specht L, Vogelius IR.
    Clin Oncol (R Coll Radiol). 2023:S0936-6555(23)00150-4. Epub ahead of print. Abstract
     
  10. Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE). Bannister WP, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, Brouw Iversen M, Schmeltz Søgaard O, Rye Ostrowski S, Breinholt Stærke N, Jakobsen ML, Olaf Lindvig S, Ruwald Juhl M, Somuncu Johansen I, Mustafa AB, Østergaard L, Dam Larsen F, Surland Knudsen L, Klastrup V, Wiese L, Benfield T, Toft Petersen K, Iversen KK, Nielsen H, Reekie J, Lundgren J; ENFORCE Study Group.
    Open Forum Infect Dis. 2023;10(6):ofad248. Abstract
     
  11. Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, on behalf of the RESPOND and D:A:D Study Groups
    Cancers. 2023. Jul 15;15(14):3640 Epub ahead of print. Abstract
     
  12. Long-term outcomes after tuberculosis for people with HIV in eastern Europe. Kraef C, Bentzon A, Roen A, Bolokadze N, Thompson M, Azina I,; Tetradov S, Skrahina A, Karpov I, Mitsura V, Paduto D, Trofimova T, Borodulina E, Mocroft A, Kirk O, Podlekareva D.
    AIDS 2023. Abstract
     
  13. Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort. Fursa O, Reekie J, Kuzin I, Hetman L, Kryshchuk A, Starychenko O, Hrytsaiuk N, Khodus I, Nyzhnyk A, Rakhuba V, Kovalevska M, Maistat T, Pryhoda I, Ahieieva M, Varvarovska O, Valdenmaiier O, Lundgren J, Peters L; CARE study group.
    J Int AIDS Soc. 2023;26(9):e26166. Abstract
     
  14. Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity. Dietz LL, Juhl AK, Søgaard OS, Reekie J, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Jensen TØ, Jakobsen SF, Olesen R, Iversen K, Fogh K, Bodilsen J, Petersen KT, Larsen L, Madsen LW, Lindvig SO, Holden IK, Raben D, Andersen SD, Hvidt AK, Andreasen SR, Baerends EAM, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
    Commun Med (Lond). 20234;3(1):58. Abstract
     
  15. Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study. Baerends EAM, Reekie J, Andreasen SR, Stærke NB, Raben D, Nielsen H, Petersen KT, Johansen IS, Lindvig SO, Madsen LW, Wiese L, Iversen MB, Benfield T, Iversen KK, Larsen FD, Andersen SD, Juhl AK, Dietz LL, Hvidt AK, Ostrowski SR, Krause TG, Østergaard L, Søgaard OS, Lundgren J, Tolstrup M.
    Clin Infect Dis. 2023:ciad402. Abstract
     
  16. Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection. Rasmussen KK, Dos Santos Q, MacPherson CR, Zucco AG, Gjærde LK, Ilett EE, Lodding I, Helleberg M, Lundgren JD, Nielsen SD, Brix S, Sengeløv H, Murray DD.
    Metabolites. 2023;13(9):968. Abstract
     

IN PRESS

 
  1. Heavy ARV exposure and exhausted/limited ARV options: predictors and clinical outcomes. Amanda Mocroft, A Pelchen-Matthews, J Hoy, JM Llibre, B Neesgaard, N Jaschinski, P Domingo, L Dahlerup Rasmussen, HF Günthard, B Surial, A Öllinger, M Knappik, S De Wit, F Wit, C Mussini, J Vehreschild, A D’Arminio Monforte, A Sonnerborg, A Castagna, A Volny Anne, V Vannappagari, C Cohen, W Greaves, JC Wasmuth, V Spagnuolo, L Ryom
  2.  Measures of longitudinal immune dysfunction and risk of AIDS and non-AIDS defining malignancies in antiretroviral treated people with HIV. Frédérique Chammartin , A. Mocroft, A. Egle, R. Zangerle, C. Smith,  C.Mussini, F. Wit, J.J. Vehrechild, A. d’Arminio Monforte, A. Castagna, L. Bailly, J. Bogner, S. de Wit, M. Raimonda, M. Law, V. Svedhem, J. Tallada, H. Garges, A. Marongiu, A. Borges, N. Jaschinski, B. Neesgaard, L. Ryom, H. C. Bucher for the RESPOND Study Group. Clinical Infectious Diseases, 2023